These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22842418)

  • 41. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids.
    Carruthers A; Carruthers J
    Dermatol Surg; 2005 Oct; 31(10):1297-303. PubMed ID: 16188182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical resistance to three types of botulinum toxin type A in aesthetic medicine.
    Stephan F; Habre M; Tomb R
    J Cosmet Dermatol; 2014 Dec; 13(4):346-8. PubMed ID: 25399628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
    Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
    Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does microneedle fractional radiofrequency system inactivate botulinum toxin type A?
    Jiang L; Liang G; Li Y; Liu L; Zhang L; Gu H; Ge L; Song Z
    J Cosmet Dermatol; 2023 Jul; 22(7):2008-2017. PubMed ID: 37195395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Skin cooling provides minimal relief of patient discomfort during periocular botulinum toxin type A injection.
    Beer KR; Wilson F
    Dermatol Surg; 2011 Jun; 37(6):870-2. PubMed ID: 21605254
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids.
    Beer KR
    Dermatol Surg; 2006 Feb; 32(2):184-97. PubMed ID: 16442037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tower microneedle via reverse drawing lithography for innocuous intravitreal drug delivery.
    Lee CY; Lee K; You YS; Lee SH; Jung H
    Adv Healthc Mater; 2013 Jun; 2(6):812-6. PubMed ID: 23209023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery.
    Lee K; Song HB; Cho W; Kim JH; Kim JH; Ryu W
    Acta Biomater; 2018 Oct; 80():48-57. PubMed ID: 30267886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation on fabrication process of dissolving microneedle arrays to improve effective needle drug distribution.
    Wang Q; Yao G; Dong P; Gong Z; Li G; Zhang K; Wu C
    Eur J Pharm Sci; 2015 Jan; 66():148-56. PubMed ID: 25446513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum A toxin for glabellar wrinkles. Dose and response.
    Hankins CL; Strimling R; Rogers GS
    Dermatol Surg; 1998 Nov; 24(11):1181-3. PubMed ID: 9834736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cosmetic uses of botulinum neurotoxin type A: an overview.
    Blitzer A; Binder WJ
    Arch Facial Plast Surg; 2002; 4(4):214-20. PubMed ID: 12437425
    [No Abstract]   [Full Text] [Related]  

  • 55. Safety and efficacy of a continuous-flow, injection-assisted device in delivery of dermal fillers.
    Lorenc ZP; Bruce S; Werschler WP
    Aesthet Surg J; 2013 Jul; 33(5):705-12. PubMed ID: 23671210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines.
    Kim JE; Song EJ; Choi GS; Lew BL; Sim WY; Kang H
    Plast Reconstr Surg; 2015 Mar; 135(3):732-741. PubMed ID: 25719692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
    Yamauchi PS; Lowe NJ
    Clin Dermatol; 2004; 22(1):34-9. PubMed ID: 15158543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Peculiarities of botulinum toxin injections for the aesthetic treatment of men's face. A review of the literature].
    Haiun M; Cardon-Fréville L; Picard F; Meningaud JP; Hersant B
    Ann Chir Plast Esthet; 2019 Jun; 64(3):259-265. PubMed ID: 31005350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IncobotulinumtoxinA in esthetics.
    Kerscher M; Yutskovskaya Y; Flynn TC
    J Drugs Dermatol; 2013 Jun; 12(6):e111-20. PubMed ID: 23839200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioceramic microneedles with flexible and self-swelling substrate.
    Cai B; Xia W; Bredenberg S; Li H; Engqvist H
    Eur J Pharm Biopharm; 2015 Aug; 94():404-10. PubMed ID: 26126420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.